Moving forward, studies in this field should prioritize conducting more standard, high-quality clinical trials to assess the safety and efficacy of novel drugs and gain deeper insights into the pathophysiological mechanisms involving CGRP in migraine. The gene discussed is CALCA; the disease is migraine disorder.